<DOC>
	<DOCNO>NCT01023971</DOCNO>
	<brief_summary>The purpose study determine change macular function anti-VEGF treatment neovascular age-related macular degeneration .</brief_summary>
	<brief_title>Macular Function During Anti-VEGF Treatment</brief_title>
	<detailed_description>Macular function investigate use visual acuity , contrast sensitivity , mfERG microperimetry .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Neovascular AMD first second eye angiographic sign active subfoveal juxtafoveal choroidal neovascularization ( CNV ) BCVA ≥35 ETDRS letter Spherical equivalent ≥ ± 6 D Previous treatment CNV study eye</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>